Bill

Bill > LD710


ME LD710

ME LD710
An Act to Expand Access and Reduce Barriers to Access to Naloxone Hydrochloride and Other Opioid Overdose-reversing Medications


summary

Introduced
02/20/2025
In Committee
02/20/2025
Crossed Over
05/22/2025
Passed
05/27/2025
Dead
Signed/Enacted/Adopted
05/29/2025

Introduced Session

132nd Legislature

Bill Summary

An Act to Expand Access and Reduce Barriers to Access to Naloxone Hydrochloride and Other Opioid Overdose-reversing Medications

AI Summary

This bill aims to expand access to naloxone hydrochloride (a medication used to reverse opioid overdoses) and other opioid overdose-reversing medications. The bill makes several key changes to existing law, including allowing over-the-counter naloxone to be provided and administered without a prescription, removing training requirements for distributing naloxone to recovery residences, and broadening liability protections for individuals and organizations providing or administering the medication. Specifically, the bill allows health care professionals, pharmacists, and community-based programs to distribute naloxone more freely, permits municipalities to maintain naloxone in publicly accessible locations (including potentially in vending machines), and provides legal immunity for people who provide or administer the medication in good faith. The changes are designed to make it easier for at-risk individuals, their family members, friends, and potential first responders to access and use opioid overdose-reversing medications quickly and without bureaucratic barriers, ultimately aiming to reduce fatalities from opioid overdoses.

Committee Categories

Health and Social Services

Sponsors (1)

Last Action

Governor's Action: Signed, May 29, 2025 (on 05/29/2025)

bill text


bill summary

Loading...

bill summary

Loading...
Loading...